Valuation: GENFIT

Market Cap 578M 0 663M 546M 496M 929M 63.63B 933M 6.54B 2.52B 32.35B 2.49B 2.44B 104B P/E 2026 *
29.8x
P/E 2027 * 65.9x
Enterprise Value 527M 0 605M 498M 452M 847M 58.01B 850M 5.96B 2.3B 29.49B 2.27B 2.22B 94.9B EV / Sales 2026 *
5.26x
EV / Sales 2027 * 4.02x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%+2.71%+0.33%+28.59% 46.28B
-1.12%+1.78%+40.07%+27.26% 43.85B
-3.04%-6.29%+322.27%+517.36% 40.93B
-0.74%+1.25%+2.32%+67.94% 39.9B
-0.50%+0.67%+11.79%+40.51% 29.5B
-0.46%+4.22%+21.99%+124.21% 17.09B
-0.97%-10.17% - - 15.55B
-0.57%+8.12%+22.15%+38.93% 15.22B
-3.14%+31.91%-10.60% - 14.05B
Average -0.99%+3.76%+51.29%+120.69% 29.15B
Weighted average by Cap. -1.02%+1.87%+64.69%+130.23%

Financials

2026 *2027 *
Net sales 100M 0 115M 94.69M 85.99M 161M 11.04B 162M 1.13B 438M 5.61B 432M 422M 18.05B 127M 0 146M 120M 109M 204M 13.98B 205M 1.44B 554M 7.11B 547M 535M 22.86B
Net income 22.88M 0 26.24M 21.6M 19.62M 36.75M 2.52B 36.91M 259M 99.86M 1.28B 98.56M 96.37M 4.12B 9.07M 0 10.4M 8.56M 7.77M 14.57M 998M 14.63M 103M 39.57M 507M 39.06M 38.19M 1.63B
Net Debt -51.11M -0 -58.61M -48.26M -43.82M -82.1M -5.62B -82.44M -578M -223M -2.86B -220M -215M -9.2B -67.56M -0 -77.48M -63.79M -57.93M -109M -7.43B -109M -764M -295M -3.78B -291M -285M -12.16B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!